	Men's Self-Reported Knowledge and Awareness Towards Male Breast Cancer in Saudi Arabia: A Cross-Sectional Study. Cancer Control Alfageh BH, Alharbi AM, Bin Saab R, Jokhab S, Kalagi NA, Almoghirah H, Alkofide H. PMID: 42993095 [PubMed - indexed for MEDLINE]
	Correction to "Proteomic Studies That Predict Patients' Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review". J Proteome Res Scanlan J, Mittal P, Oehler MK, Hoffmann P, Klingler-Hoffmann M. PMID: 42992929 [PubMed - in process]
	Global Burden and Risk Factors of Breast Cancer in Female Adolescents and Young Adults, 1990-2021: Results from the Global Burden of Disease Study 2021. Balkan Med J Su Y, Wen F, Hu J, Yang Y, Wang Y. PMID: 42992848 [PubMed - as supplied by publisher]
	Cervicovaginal microbiome modulates HPV genotype-specific clearance/persistence: role of bacterial dysbiosis in cervical carcinogenesis. Ann Med Zhang J, Ji M, Lv N, Zhou Y. PMID: 42992718 [PubMed - indexed for MEDLINE]
	Competing Endogenous Ribonucleic Acid Networks in Cervical Cancer: Mechanisms and Clinical Implications. J Vis Exp Shi L, Khan MU. PMID: 42992712 [PubMed - indexed for MEDLINE]
	Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05. Future Oncol Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, Martins de Aquino Pimentel LC, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Muelle V, Yang S, Granata G, Shen Q, Hamilton E. PMID: 42992631 [PubMed - as supplied by publisher]
	The effectiveness of virtual reality-assisted relaxation therapy in improving psychological symptoms and fatigue of breast cancer survivors: a systematic review and meta-analysis. Front Oncol Deng Y, Chen Y, Mo J, Liang Y, Yu S, Bai X. PMID: 42992359 [PubMed]
	Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials. JCO Oncol Adv Felsheim BM, Huober J, Carey LA, Nekljudova V, Karn T, Tolaney SM, Schneeweiss A, Untch M, Salat C, Kuzma CS, Fernandez-Martinez A, Rachakonda S, Ponce-Lorenzo JJ, Zahm DM, Suresh R, Stover DG, Rastogi P, Darsow M, Lake DE, Rugo HS, O'Shaughnessy J, Golshan M, Pfefferle AD, Sikov WM, Metzger O, Denkert C, Geyer CE Jr, Perou CM, Loibl S. PMID: 42992319 [PubMed]
	Redefining axillary management by selecting patients for omission of sentinel lymph node surgery in early breast cancer. Explor Target Antitumor Ther Tjalma W, Coenen S. PMID: 42992311 [PubMed]
	Targeting histone methylation with ROS nanoparticles delivering PARPi prodrugs to amplify the stimulation of cGAS-STING for immunotherapy in ovarian cancer. Mater Today Bio Sun Y, Li H, Zhang H, Zhang H, Xu C, Li B, Xiao H, Zhao D. PMID: 42992080 [PubMed]
	Pseudo-pseudo Meigs Syndrome as the first clinical manifestation of systemic lupus erythematosus after controlled ovarian stimulation for ICSI: a case report. Front Immunol Li S, Zhao D, Zhang M. PMID: 42991812 [PubMed - indexed for MEDLINE]
	Lived experiences of psychosocial and quality of life outcomes for adults newly diagnosed with breast cancer in interior British Columbia: qualitative research. Front Glob Womens Health D'Souza MS, Manish A, Nette H, Bacsu JR. PMID: 42991539 [PubMed]
	Non-malignant breast cancer-related breast edema: an overview. Transl Breast Cancer Res Deehan E, Harb R, Mayrovitz H. PMID: 42991475 [PubMed]
	The vascular-immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers. Front Oncol Zhang Y, Yulan C, Long K, Wang Q, Liu C, Zeng F. PMID: 42991471 [PubMed]
	Benefits and adverse events of combined chemotherapy and immune checkpoint inhibition in non-metastatic triple-negative breast cancer: a systematic review and an updated meta-analysis. Transl Breast Cancer Res Wu J, Zhang K. PMID: 42991457 [PubMed]
	Sacituzumab govitecan plus toripalimab compared with toripalimab plus nab-paclitaxel for first-line treatment of unresectable, locally advanced, or metastatic triple-negative breast cancer: protocol of a multicenter, open-label, randomized phase II trial. Transl Breast Cancer Res Zhang S, Zhao J, Ling X, Mo X, Li M, Yao H, Jiang Z. PMID: 42991455 [PubMed]
	Multi-omics of tertiary lymphoid structures in breast cancer: clinical significance and biomarker potential. Front Immunol Chen C, Song H. PMID: 42991413 [PubMed - indexed for MEDLINE]
	Dose- and time-resolved immune states in cervical cancer radiotherapy: dynamic multimodal biomarkers for adaptive immunoradiotherapy. Front Immunol Xiao C, Tian F, Kang M, Xie F. PMID: 42991331 [PubMed - indexed for MEDLINE]
	Risk factors for persistent high-risk HPV infection and recurrence burden of vaginal infections in women with cervical low-grade squamous intraepithelial lesions: a retrospective cohort study. Front Cell Infect Microbiol Bai R, Tang Z, Ji C, Tang L, Liu Y, Luo M. PMID: 42991228 [PubMed - indexed for MEDLINE]
	Immune remodeling of breast tumor-draining lymph nodes: antigen-presenting cell dysfunction, regulatory T-cell expansion, and premetastatic niche formation. Front Immunol Zeng L, Wu H, Xue S, Chen M, Song J, Lin W. PMID: 42991081 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 337698

Page 1 of 16885



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy